Literature DB >> 20716952

Driver mutations: a roadmap for getting close and personal in pancreatic cancer.

Murray Korc1.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20716952      PMCID: PMC3040949          DOI: 10.4161/cbt.10.6.13128

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  30 in total

Review 1.  Kinase signaling pathways as targets for intervention in pancreatic cancer.

Authors:  Meir Preis; Murray Korc
Journal:  Cancer Biol Ther       Date:  2010-05-15       Impact factor: 4.742

2.  DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RAS.

Authors:  Matthias Lauth; Asa Bergström; Takashi Shimokawa; Ulrica Tostar; Qianren Jin; Volker Fendrich; Carmen Guerra; Mariano Barbacid; Rune Toftgård
Journal:  Nat Struct Mol Biol       Date:  2010-05-30       Impact factor: 15.369

3.  Primary cilia regulate Gli/Hedgehog activation in pancreas.

Authors:  Sara Cervantes; Janet Lau; David A Cano; Cecilia Borromeo-Austin; Matthias Hebrok
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

4.  Aurora-A phosphorylates, activates, and relocalizes the small GTPase RalA.

Authors:  Kian-Huat Lim; Donita C Brady; David F Kashatus; Brooke B Ancrile; Channing J Der; Adrienne D Cox; Christopher M Counter
Journal:  Mol Cell Biol       Date:  2009-11-09       Impact factor: 4.272

Review 5.  The primary cilium: a signalling centre during vertebrate development.

Authors:  Sarah C Goetz; Kathryn V Anderson
Journal:  Nat Rev Genet       Date:  2010-05       Impact factor: 53.242

6.  Prioritization of driver mutations in pancreatic cancer using cancer-specific high-throughput annotation of somatic mutations (CHASM).

Authors:  Hannah Carter; Josue Samayoa; Ralph H Hruban; Rachel Karchin
Journal:  Cancer Biol Ther       Date:  2010-10-01       Impact factor: 4.742

7.  The stem cell factor-c-kit system and mast cells in human pancreatic cancer.

Authors:  Irene Esposito; Jörg Kleeff; Stephan C Bischoff; Lars Fischer; Paola Collecchi; Mariacarla Iorio; Generoso Bevilacqua; Markus W Büchler; Helmut Friess
Journal:  Lab Invest       Date:  2002-11       Impact factor: 5.662

Review 8.  Pancreatic cancer biology and genetics.

Authors:  Nabeel Bardeesy; Ronald A DePinho
Journal:  Nat Rev Cancer       Date:  2002-12       Impact factor: 60.716

Review 9.  Inflammation and the development of pancreatic cancer.

Authors:  Buckminster Farrow; B Mark Evers
Journal:  Surg Oncol       Date:  2002-05       Impact factor: 3.279

Review 10.  Targeting the PI3K signaling pathway in cancer.

Authors:  Kwok-Kin Wong; Jeffrey A Engelman; Lewis C Cantley
Journal:  Curr Opin Genet Dev       Date:  2009-12-16       Impact factor: 5.578

View more
  13 in total

1.  A single nucleotide polymorphism of the cholecystokinin-B receptor predicts risk for pancreatic cancer.

Authors:  Jill P Smith; John F Harms; Gail L Matters; Christopher O McGovern; Francesca M Ruggiero; Jiangang Liao; Kristin K Fino; Emily E Ortega; Evan L Gilius; John A Phillips
Journal:  Cancer Biol Ther       Date:  2012-02-01       Impact factor: 4.742

2.  Downregulation of the CCK-B receptor in pancreatic cancer cells blocks proliferation and promotes apoptosis.

Authors:  Kristin K Fino; Gail L Matters; Christopher O McGovern; Evan L Gilius; Jill P Smith
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-22       Impact factor: 4.052

Review 3.  Etiology and Risk Factors of Acute and Chronic Pancreatitis.

Authors:  Frank Ulrich Weiss; Felix Laemmerhirt; Markus M Lerch
Journal:  Visc Med       Date:  2019-03-13

4.  A Biomimetic Tumor Model of Heterogeneous Invasion in Pancreatic Ductal Adenocarcinoma.

Authors:  Michael J Bradney; Stephanie M Venis; Yi Yang; Stephen F Konieczny; Bumsoo Han
Journal:  Small       Date:  2020-01-30       Impact factor: 13.281

Review 5.  Combination Therapies and Drug Delivery Platforms in Combating Pancreatic Cancer.

Authors:  Fan Lei; Xinyuan Xi; Surinder K Batra; Tatiana K Bronich
Journal:  J Pharmacol Exp Ther       Date:  2019-02-22       Impact factor: 4.030

Review 6.  Novel strategies for managing pancreatic cancer.

Authors:  Welley S Loc; Jill P Smith; Gail Matters; Mark Kester; James H Adair
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

7.  Use of molecular studies for treatment of metastatic pleomorphic large cell pancreatic cancers-a novel strategy.

Authors:  Parikshit Padhi; Arshjyot Narula; Anna Balog; Antonios Christou
Journal:  J Gastrointest Oncol       Date:  2016-04

8.  Keratinocyte growth factor induces matrix metalloproteinase-9 expression and correlates with venous invasion in pancreatic cancer.

Authors:  Kazumitsu Cho; Yoko Matsuda; Junji Ueda; Eiji Uchida; Zenya Naito; Toshiyuki Ishiwata
Journal:  Int J Oncol       Date:  2011-12-06       Impact factor: 5.650

Review 9.  Pancreatic cancer risk in hereditary pancreatitis.

Authors:  Frank U Weiss
Journal:  Front Physiol       Date:  2014-02-20       Impact factor: 4.566

10.  Gradual telomere shortening and increasing chromosomal instability among PanIN grades and normal ductal epithelia with and without cancer in the pancreas.

Authors:  Yoko Matsuda; Toshiyuki Ishiwata; Naotaka Izumiyama-Shimomura; Hideki Hamayasu; Mutsunori Fujiwara; Ken-Ichiro Tomita; Naoki Hiraishi; Ken-Ichi Nakamura; Naoshi Ishikawa; Junko Aida; Kaiyo Takubo; Tomio Arai
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.